CAS: 16315-59-6; 4-Dimethlaminophenylisocyanate

该化合物是一种有机化合物,其特征是配有二甲基氨基苯二甲酸酯功能组(-N=C=O),附于二甲基氨基苯二甲基苯二甲基苯二甲基苯二氧基乙酸酯,该化合物一般是黄色至褐色液体,以其反应作用著称,特别是在形成氨基乙烷和其他衍生物时,它溶于有机溶剂,但在水中溶解程度有限;二甲基氨基组的存在具有基本特性,使其在各种化学反应中具有潜在的核素.由于异丙酸的功能,必须谨慎地处理这一化合物,因为据知异氰酸盐具有毒性,可引起呼吸刺激和敏化.适当的安全措施,包括使用个人防护设备,以及在通风良好的地区或烟雾帽区工作,在与该物质合作时至关重要.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号70843-95-7 4-(dimethylamin... | CAS号32315-10-9 三光气 | CAS号99-98-9 对氨基-N,N-二甲基苯胺 | CAS号75057-89-5 4-dimethylamino... | CAS号503-38-8 氯甲酸三氯甲酯 | CAS号619-84-1 4-二甲氨基苯甲酸 | CAS号4755-50-4 4-二甲氨基苯甲酰氯 | CAS号1202-25-1 4-二甲氨基苯甲酸甲酯 | CAS号19353-92-5 对二甲氨基苯甲酰肼 | CAS号108-88-3 甲苯 | CAS号111256-83-8 4-[4-(dimethyla... | CAS号883455-55-8 4-[4-(二甲基氨基)苯基]... | CAS号78823-56-0 methyl N-[4-(di...

合成工艺路线路线简述

    📜N,N-二甲基-对苯二胺置于三乙胺体系中,用 甲苯 用作溶剂,化学反应生成4-二甲氨基苯异氰酸酯
    参考文献:Pyrazolidinone Cck And Gastrin Antagonists And Pharmaceutical
    标题:Pyrazolidinone Cck And Gastrin Antagonists And Pharmaceutical
    摘要:已发现新型取代吡唑啉酮具有显著的结合胆囊收缩素(cck)受体和胃泌素受体的能力,这些受体位于大脑和/或外周部位,如胰腺,胃和回肠.这些吡唑啉酮是cck和胃泌素受体拮抗剂,并在治疗消化系统疾病,中枢神经系统疾病以及温血脊椎动物的食欲调控中找到了治疗应用.描述了用于这些适应症的药物配方.

    海关参考信息

    专利信息


    专利号:US-7138526-B1
    优先权日:1999-06-15
    标 题 :Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
    发明人:HERPIN TIMOTHY F; MORTON GEORGE C; SALVINO JOSEPH M
    权利人:AVENTIS PHARMA INC
    摘要:A method for the solid phase synthesis of N,N-disubstituted diazacycloalkylcarboxy derivatives of general formula (I) and (II) is claimed. Examples include piperazine-2-carboxamide. The method is applicable to the synthesis or large combinatorial libraries

    专利号:US-9879050-B2
    优先权日:2013-08-30
    标 题 :Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase
    发明人:LEE RICHARD E; ZHAO YING; GRIFFITH ELIZABETH; ZHENG ZHONG; SINGH AMAN P
    权利人:ST JUDE CHILDREN'S RES HOSPITAL
    摘要:In one aspect, the invention relates to substituted urea depsipeptide analogs, derivatives thereof, and related compounds, which are useful as activators the ClpP endopeptidease; synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating infectious disease using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:US-8012972-B2
    优先权日:2007-03-28
    标 题:Pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
    发明人:MOGI HIROYUKI; TAJIMA HISASHI; MISHINA NORIKO; YAMAZAKI YUSUKE; YONEDA SHINJI; WATANABE KATSUHIKO; FUJIKAWA JUNKO; YAMAMOTO MINORU
    权利人:SANTEN PHARMACEUTICAL CO LTD
    摘要:Objects of the present invention are to study the synthesis of a novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having a novel urea structure and to find a pharmacological effect of the derivative. The invention provides a compound represented by the formula (1) or a salt thereof. In the formula, R 1 and R 2 represent a hydrogen atom, a lower alkyl group or the like; R 3 represents a hydroxy group, a lower alkoxy group, a lower cycloalkyloxy group, an aryloxy group, a carboxy group, a lower alkoxycarbonyl group, —OCONR a R b , —NR c R d or the like; R 4 and R 5 represent a halogen atom, a lower alkyl group, a hydroxy group, a lower alkoxy group or the like; R a and R b represent a hydrogen atom, a lower alkyl group, a lower cycloalkyl group, an aryl group, a heterocyclic group or the like; R c and R d represent a hydrogen atom, a lower alkyl group, a lower cycloalkyl group, an aryl group or the like; X represents a lower alkylene group; Y represents a single bond, a lower alkylene group; W 1 -W 2 represents N—C or C—N; and l and m represent 0, 1, 2 or 3.

    专利号:US-10822377-B2
    优先权日:2015-03-04
    标 题:Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase
    发明人:LEE RICHARD E; ZHAO YING; JIUYU LIU
    权利人:ST JUDE CHILDRENS RES HOSPITAL
    摘要:In one aspect, the invention relates to substituted urea depsipeptide analogs, derivatives thereof, and related compounds, which are useful as activators the ClpP endopeptidease; synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating infectious disease using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:EP-1200824-B1
    优先权日:1999-06-15
    标题:Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives

    专利号:US-7615634-B2
    优先权日:2003-02-10
    标题:4-aminopyrimidine-5-one derivatives
    发明人:BARTKOVITZ DAVID JOSEPH; CHU XIN-JIE; DING QINGJIE; JIANG NAN; LOVEY ALLEN JOHN; MOLITERNI JOHN ANTHONY; MULLIN JR JOHN GUILFOYLE; VU BINH THANH; WOVKULICH PETER MICHAEL
    权利人:HOFFMANN LA ROCHE
    摘要:Novel intermediate compounds are disclosed. These compounds are useful in the synthesis of 4-aminopyrimidine-5-one derivatives that inhibit cyclin-dependent kinases, in particular cyclin-dependent kinase 4 (Cdk4). The 4-aminopyrimidine-5-one derivatives and their pharmaceutically acceptable salts have antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00216-024-05651-9
    摘要:Thiebot P, Magny R, Martins P, Houze P, Bloch V, Vorspan F, Auzeil N, Labat L. Quantitative analysis of cannabinoids and metabolites in oral fluid by volumetric absorptive microsampling combined with UHPLC-HRMS. Anal Bioanal Chem. 2025 Jan;417(2):345–60. doi: 10.1007/s00216-024-05651-9.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知